Paper2140397
Heterogeneity of human lipoprotein Lp[a]: cytochemical and biochemical studies on the interaction of two Lp[a] species with the LDL receptor.
Armstrong VW and 5 others. J Lipid Res, 1990. Cited by 91 papers, by iCite.
Cite this record
ConductScience Library. Heterogeneity of human lipoprotein Lp[a]: cytochemical and biochemical studies on the interaction of two Lp[a] species with the LDL receptor. Papers, record 2140397. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/2140397
- Sources
- 11 sources
- Release
- papers-2026-11-12-0.1.0
Paper
PubMed's record of the paper, with iCite's citation figures. No abstract is shown.
- Title
- Heterogeneity of human lipoprotein Lp[a]: cytochemical and biochemical studies on the interaction of two Lp[a] species with the LDL receptor.
- PubMed
Topics20
NLM's MeSH indexing of the paper, its major topics first.
| MeSH term | Major |
|---|---|
| Lipoproteins | Major topic |
| Receptors, LDL | Major topic |
| Affinity Labels | |
| Animals | |
| Cells, Cultured | |
| Cholesterol Esters | |
| Chromatography, Affinity | |
| Electrophoresis, Agar Gel | |
| Fibroblasts | |
| Humans | |
| Immunohistochemistry | |
| Lipoprotein(a) | |
| Lipoproteins, LDL | |
| Liver | |
| Male | |
| Perfusion | |
| Rats | |
| Rats, Inbred Strains | |
| Sepharose | |
| Sterols |
Source PubMed
Cited by15
The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 91 citations.
| PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|
| 30727753 | Race-Based Differences in Lipoprotein(a)-Associated Risk of Carotid Atherosclerosis. | Arterioscler Thromb Vasc Biol | 2019 | https://conductscience.org/library/papers/30727753 | PubMed |
| 28798072 | The roles of apo(a) size, phenotype, and dominance pattern in PCSK9-inhibition-induced reduction in Lp(a) with alirocumab. | J Lipid Res | 2017 | https://conductscience.org/library/papers/28798072 | PubMed |
| 27102113 | PCSK9 inhibition-mediated reduction in Lp(a) with evolocumab: an analysis of 10 clinical trials and the LDL receptor's role. | J Lipid Res | 2016 | https://conductscience.org/library/papers/27102113 | PubMed |
| 25120086 | Lipoprotein (a): structure, pathophysiology and clinical implications. | Arq Bras Cardiol | 2014 | https://conductscience.org/library/papers/25120086 | PubMed |
| 15134578 | Human apoB contributes to increased serum total apo(a) level in LPA transgenic mice. | Lipids Health Dis | 2004 | https://conductscience.org/library/papers/15134578 | PubMed |
| 12573195 | Lipoprotein(a) and the atherothrombotic process: mechanistic insights and clinical implications. | Curr Atheroscler Rep | 2003 | https://conductscience.org/library/papers/12573195 | PubMed |
| 9590626 | Enhanced macrophage uptake of lipoprotein(a) after Ca2+-induced aggregate-formation. | Lipids | 1998 | https://conductscience.org/library/papers/9590626 | PubMed |
| 9385634 | Oxidation of apolipoprotein(a) inhibits kringle-associated lysine binding: the loss of intrinsic protein fluorescence suggests a role for tryptophan residues in the lysine binding site. | Protein Sci | 1997 | https://conductscience.org/library/papers/9385634 | PubMed |
| 9239402 | Modification of apolipoprotein(a) lysine binding site reduces atherosclerosis in transgenic mice. | J Clin Invest | 1997 | https://conductscience.org/library/papers/9239402 | PubMed |
| 8432847 | Elevated plasma concentrations of lipoprotein(a) in patients with end-stage renal disease are not related to the size polymorphism of apolipoprotein(a). | J Clin Invest | 1993 | https://conductscience.org/library/papers/8432847 | PubMed |
| 8096495 | A PvuII polymorphism of the low density lipoprotein receptor gene is not associated with plasma concentrations of low density lipoproteins including LP(a). | Hum Genet | 1993 | https://conductscience.org/library/papers/8096495 | PubMed |
| 7989589 | The role of lecithin: cholesterol acyltransferase for lipoprotein (a) assembly. Structural integrity of low density lipoproteins is a prerequisite for Lp(a) formation in human plasma. | J Clin Invest | 1994 | https://conductscience.org/library/papers/7989589 | PubMed |
| 7883987 | The low density lipoprotein receptor is not required for normal catabolism of Lp(a) in humans. | J Clin Invest | 1995 | https://conductscience.org/library/papers/7883987 | PubMed |
| 7868118 | Sequence polymorphism in kringle IV 37 in linkage disequilibrium with the apolipoprotein (a) size polymorphism. | Hum Genet | 1995 | https://conductscience.org/library/papers/7868118 | PubMed |
| 1830890 | Relationship between apolipoprotein(a) phenotype, lipoprotein(a) concentration in plasma, and low density lipoprotein receptor function in a large kindred with familial hypercholesterolemia due to the pro664----leu mutation in the LDL receptor gene. | J Clin Invest | 1991 | https://conductscience.org/library/papers/1830890 | PubMed |
Genes1
The genes the Gene search release ties to the paper: Swiss-Prot's references first, then PubTator's text mining.
| Gene | NCBI Gene ID | Linked by | In Genes |
|---|---|---|---|
| LDLR | 3949 | PubTator's text mining | https://conductscience.org/library/genes/3949 |
Source NCBI Gene
Data dates
The date of each source this release read.
- Trials
- 2026-11-12
- Gene search
- 2026-11-11
- Pipelines
- 2026-09-18
None in this release
- Grants
- Trials
- Comments and corrections
- References
- Drugs
- Data
Sources 11
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- HGNCCC0
- iCiteCC BY 4.0
- NCBI GenePublic domain (US government)
- NIH RePORTER's grant and paper linksPublic domain
- Open TargetsCC0 1.0
- PMC's ID filePublic domain (US government)
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- HGNCCC0: https://www.genenames.org/about/license/
- iCiteCC BY 4.0
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this paper from software.
The record and each of its lists are JSON, twenty rows a page. No key.
GET https://conductscience.org/api/papers/v1/2140397
GET https://conductscience.org/api/papers/v1/2140397/authors